IRVAX Mutual Fund

NAV$32.13

Fund Essentials - as of Apr 30, 2026

Net Assets
$6,789.94
Expense Ratio
0.93%
Dividend Yield (Current)
3.45%
Holdings
159
Inception Date
Jul 13, 2015
Fund Family
Voya Investment Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+14.13%
1 Year+26.06%
3 Year+17.44%
5 Year+11.09%
10 Year+11.03%

Asset Allocation

Stocks: 99.38%
Other: 0.62%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
BRK.BBrk/B3.91%
JPM:USJp Morgan Chase & Co3.81%
GOOGL'alphabet Inc., Class 'a''3.55%
AMZNAmazon.Com Inc3.13%
XOMExxon Mobil Corp.2.92%
Top 10 Concentration: 29.42%Report Date: Apr 30, 2026
Download all 159 holdings for IRVAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.45%
Frequency
Annually
Latest Distribution
$0.44
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how IRVAX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

IRVAX Mutual Fund Overview

IRVAX Mutual Fund (Voya Russell Large Cap Value Index Portfolio Advisor Class) is managed by Voya Investment Management with $6,789.94 in net assets. IRVAX expense ratio is 0.93%, holding 159 positions across sectors including Unknown, Financials, Industrials. Inception date: 2015-07-13.

IRVAX performance shows a YTD return of 14.13%. The 1-year return is 26.06% and the 5-year return is 11.09%. IRVAX dividend yield stands at 3.45%, paid annually.

IRVAX top holdings include Brk/B (3.9%), Jp Morgan Chase & Co (3.8%), 'alphabet Inc., Class 'a'' (3.5%), Amazon.Com Inc (3.1%), Exxon Mobil Corp. (2.9%). View all IRVAX holdings, sector breakdown, or dividend history.

IRVAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. IRVAX alternatives are available via the screener, along with tax-loss harvesting opportunities.